ArticleMolecular therapy. Nucleic acids2026

An antisense oligonucleotide targeting STK25 as a long-acting therapeutic candidate for early MASLD.

Ao Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.